Indiana legislators may soon return to discussions surrounding medical cannabis, though state officials say there is still uncertainty about whether federal action will prompt any immediate changes in state policy.
During a meeting on May 11, members of the Indiana Board of Pharmacy examined a federal notice concerning cannabis rescheduling. However, the board did not move forward with any decisions, emphasizing that Indiana would only consider a response once the federal government formally completes the process. As a result, existing cannabis laws in the state remain intact for the time being.
Despite the uncertainty, state senator Mike Bohacek has revealed plans to introduce legislation in 2027 aimed at legalizing medical cannabis in the state while establishing guidelines for how it would be sold and prescribed.
Bohacek said renewed conversations are necessary as state leaders appear increasingly willing to evaluate marijuana-related policies. He argued that medical cannabis could offer relief to residents suffering from certain health conditions while also creating economic opportunities.
The expected proposal signals another likely clash at the Statehouse, where efforts to loosen cannabis restrictions have repeatedly stalled. Indiana remains one of the few states without a medical cannabis system, even as neighboring states have expanded access or approved broader legalization measures.
Last month, Governor Mike Braun suggested he was open to broader conversations about cannabis regulation. While he stopped short of supporting full legalization, Braun said lawmakers should explore possible frameworks and policy recommendations for how the state might proceed.
At the federal level, the situation remains unresolved. Although the DOJ recently announced a limited move to classify some state-authorized medical cannabis products under Schedule 3, wider federal reclassification is still under review by the DEA. Hearings tied to the issue are expected to start next month.
State pharmacy board attorney Leif Johnson said Indiana law requires officials to examine finalized federal changes before deciding whether similar updates should apply at the state level. If board members oppose a federal adjustment, they must publicly explain their objections and allow time for hearings before any recommendation advances.
Earlier this year, legislators again failed to agree on cannabis legislation. A Senate-backed effort targeting intoxicating hemp-derived THC products collapsed before the legislative session concluded.
Bohacek said his proposal would include strict safeguards, additional police training on THC impairment, and clear medical-use standards. He also argued that Indiana should consider taxing cannabis-related products already being sold, saying such policies could generate millions in annual revenue for the state.
The marijuana industry, including companies like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), hopes that Indiana lawmakers consider the wishes of the people in the state and enact regulations that address the needs of residents.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
